Skip to main content

News & Insights

Press Release

TPG Recognized as Industry Leader by Private Equity International

SAN FRANCISCO & FORT WORTH, Texas—March 1, 2023—TPG Inc. (NASDAQ: TPG), a leading global alternative asset management firm, is honored to have been selected for four prestigious Private Equity International (“PEI”) awards in 2022.

  • Large-Cap Firm of the Year, North America
  • Technology Private Equity Firm of the Year
  • Impact Investment Firm of the Year
  • Deal of the Year in Asia (iNova Pharmaceuticals)

“2022 was a milestone year for TPG and we’re pleased to be recognized as PEI’s North American Firm of the Year,” said Jon Winkelried, Chief Executive Officer. “Our IPO was the culmination of a massive effort across our teams, and since going public, we have continued to develop innovative strategies, invest with excellence across platforms and geographies, and take a strategic approach to operational excellence. This recognition reflects the quality of our people and we look forward to accelerating this momentum in 2023 and beyond.”

TPG was also recognized in core sectors and geographies:

Named as Technology Private Equity Firm of the Year

TPG is one of the most active and experienced technology investors, having invested $37 billion into the sector since the firm’s inception. TPG’s tech franchise is comprised of two sector teams that invest across the space: Software and Enterprise Technology (S&ET), and Internet, Digital Media, and Communications (IDMC).

Second Consecutive Year Named as Impact Investment Firm of the Year

TPG Rise is TPG’s global impact investing platform. With more than $16 billion in assets under management across The Rise Funds, TPG Rise Climate, the Evercare Health Fund, and most-recently the addition of TPG NEXT, we believe TPG Rise is the world’s largest private markets impact investing platform committed to fostering measurable, positive social and environmental outcomes alongside competitive financial returns.

Awarded Deal of the Year in Asia (iNova Pharmaceuticals)

TPG Asia closed its acquisition of iNova Pharmaceuticals in October 2022. iNova is one of the largest independent consumer healthcare companies in the Asia Pacific region, with a broad portfolio across respiratory, skin care, medicinal, pain, and weight management. The investment reflects TPG Asia’s capabilities including: building regional platforms at scale, sector specialization in consumer and healthcare, and investing behind growth.

"These awards from PEI are a testament to the hard work, innovation, and partnership that takes place every day across our teams, portfolio, and the broader TPG ecosystem," added Jim Coulter, TPG’s Co-Founder and Executive Chairman. "We’ve built our platforms purposefully, with a focus on sectors and geographies where we can deliver long-term value. As we continue to grow and expand our offerings, we are proud to be recognized for our investing leadership in Tech, Impact, and Asia. We believe we have a distinct position in the market, at a time when the market continues to seek differentiation and are excited about the opportunities ahead.”

About TPG

TPG is a leading global alternative asset management firm, founded in San Francisco in 1992, with $135 billion of assets under management and investment and operational teams around the world. TPG invests across five multi-product platforms: Capital, Growth, Impact, Real Estate, and Market Solutions and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities. For more information, visit or @TPG on Twitter.

The above includes a representative sample of awards based on investment activity and firm profile. The awards were given on March 1, 2023 from PEI for the period of Q4 2021 through Q4 2022. The sample of awards are for illustrative purpose only and does not necessarily represent the experience of any investor. No compensation was paid for awards or ratings.


Gary Stein



Luke Barrett


This site uses cookies so that we can analyze how it is used and improve the site and your experience.

You can change your preferences at any time.